Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.76
+0.17 (0.44%)
At close: Oct 30, 2026, 4:00 PM EDT
38.63
-0.13 (-0.34%)
After-hours: Oct 30, 2026, 7:36 PM EDT
HRMY Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $48.08. The average 1-year stock price forecast is 24.05% higher than the current stock price, while the lowest is $30 (-22.60%) and the highest is $70 (+80.60%).
Price Target: $48.08 (+24.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $51 → $49 | Buy | Maintains | $51 → $49 | +26.42% | Oct 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $55 | Buy | Reiterates | $55 | +41.90% | Oct 27, 2026 |
| Needham | Needham | Buy Reiterates $50 | Buy | Reiterates | $50 | +29.00% | Oct 19, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $55 | Buy | Initiates | $55 | +41.90% | Oct 15, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $30 | Sell | Maintains | $30 | -22.60% | Oct 12, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 868.45M
Increased by 18.17%
Revenue Next Year
1.17B
from 1.03B
Increased by 13.71%
EPS This Year
5.22
from 3.60
Increased by 45.05%
EPS Next Year
7.00
from 5.22
Increased by 34.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.